Synopsis
0
CEP/COS
0
VMF
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Thickeners and Stabilizers
Parenteral
Coating Systems & Additives
Taste Masking
Topical
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Trabectedin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trabectedin, including repackagers and relabelers. The FDA regulates Trabectedin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trabectedin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trabectedin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trabectedin supplier is an individual or a company that provides Trabectedin active pharmaceutical ingredient (API) or Trabectedin finished formulations upon request. The Trabectedin suppliers may include Trabectedin API manufacturers, exporters, distributors and traders.
click here to find a list of Trabectedin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trabectedin DMF (Drug Master File) is a document detailing the whole manufacturing process of Trabectedin active pharmaceutical ingredient (API) in detail. Different forms of Trabectedin DMFs exist exist since differing nations have different regulations, such as Trabectedin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trabectedin DMF submitted to regulatory agencies in the US is known as a USDMF. Trabectedin USDMF includes data on Trabectedin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trabectedin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trabectedin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trabectedin Drug Master File in Japan (Trabectedin JDMF) empowers Trabectedin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trabectedin JDMF during the approval evaluation for pharmaceutical products. At the time of Trabectedin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trabectedin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Trabectedin Drug Master File in Korea (Trabectedin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Trabectedin. The MFDS reviews the Trabectedin KDMF as part of the drug registration process and uses the information provided in the Trabectedin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Trabectedin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Trabectedin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Trabectedin suppliers with KDMF on PharmaCompass.
A Trabectedin written confirmation (Trabectedin WC) is an official document issued by a regulatory agency to a Trabectedin manufacturer, verifying that the manufacturing facility of a Trabectedin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trabectedin APIs or Trabectedin finished pharmaceutical products to another nation, regulatory agencies frequently require a Trabectedin WC (written confirmation) as part of the regulatory process.
click here to find a list of Trabectedin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trabectedin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trabectedin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trabectedin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trabectedin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trabectedin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trabectedin suppliers with NDC on PharmaCompass.
Trabectedin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trabectedin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trabectedin GMP manufacturer or Trabectedin GMP API supplier for your needs.
A Trabectedin CoA (Certificate of Analysis) is a formal document that attests to Trabectedin's compliance with Trabectedin specifications and serves as a tool for batch-level quality control.
Trabectedin CoA mostly includes findings from lab analyses of a specific batch. For each Trabectedin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trabectedin may be tested according to a variety of international standards, such as European Pharmacopoeia (Trabectedin EP), Trabectedin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trabectedin USP).
LOOKING FOR A SUPPLIER?
